Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Short-term Investments: 2019-2024

Historic Short-term Investments for Revolution Medicines (RVMD) over the last 6 years, with Dec 2024 value amounting to $1.7 billion.

  • Revolution Medicines' Short-term Investments rose 27.14% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 27.14%. This contributed to the annual value of $1.7 billion for FY2024, which is 50.95% up from last year.
  • Revolution Medicines' Short-term Investments amounted to $1.7 billion in FY2024, which was up 50.95% from $1.2 billion recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Short-term Investments registered a high of $1.7 billion during FY2024, and its lowest value of $336.5 million during FY2020.
  • Its 3-year average for Short-term Investments is $1.1 billion, with a median of $1.2 billion in 2023.
  • Data for Revolution Medicines' Short-term Investments shows a peak YoY skyrocketed of 217.13% (in 2020) over the last 5 years.
  • Revolution Medicines' Short-term Investments (Yearly) stood at $336.5 million in 2020, then soared by 39.26% to $468.6 million in 2021, then increased by 3.20% to $483.5 million in 2022, then soared by 139.24% to $1.2 billion in 2023, then soared by 50.95% to $1.7 billion in 2024.